Keywords: galileo, raises, 1m, changes, name, montreal, canada-headquartered

Galileo raises C$11.1M and changes name

Article | 20 December 2004

Montreal, Canada-headquartered drug target discovery group Galileo Genomics has raised C$11.1 million ($9.2 million) in a series B financing round, led ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

MVI

Go to drug listing